Ettrup, A; Hansen, M; Santini, MA; Paine, J; Gillings, N; Palner, M; Lehel, S; Herth, MM; Madsen, J; Kristensen, JL; Begtrup, M; Knudsen, GM. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers Eur. J. Nucl. Med. Mol. Imaging, 1 Apr 2011, 38 (4), 681–693. 752 kB. https://doi.org/10.1007/s00259-010-1686-8 #Cimbi-36 LC
Heim, R. Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. 3.9 MB. #231 In German. MS,NMR,IR
Anon. JW, Personal communication of unpublished research 1 Dec 2011.
Silva, ME; Heim, R; Strasser, A; Elz, S; Dove, S. Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor J. Comput. Aided Mol. Des., 1 Jan 2011, 25 (1), 51–66. 834 kB. https://doi.org/10.1007/s10822-010-9400-2 #21
Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5.9 MB. #231
Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7.9 MB. #2.5 NMR
Casale, JF; Hays, PA. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues—Part I Microgram J., 1 Jan 2012, 9 (2), 84–109. 4.6 MB. #4: 25B-NB2OMe GC,MS,IR
Ettrup, A; Holm, S; Hansen, M; Wasim, M; Santini, MA; Palner, M; Madsen, J; Svarer, C; Kristensen, JL; Knudsen, GM. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [11C]Cimbi-36 Mol. Imaging Biol., 1 Aug 2013, 15 (4), 376–383. 374 kB. https://doi.org/10.1007/s11307-012-0609-4
Poklis, JL; Nanco, CR; Troendle, MM; Wolf, CE; Poklis, A. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication Drug Test. Anal., 1 Jul 2014, 6 (7-8), 764-769. 292 kB. https://doi.org/10.1002/dta.1522 LC
Heim, R; Elz, S. Novel extremely potent partial 5-HT2A-receptor agonists: Successful application of a new structure-activity concept Arch. Pharm. Pharm. Med. Chem., , 333 (Suppl. 1), 18. 566 kB. #1 Poster abstract
Heim, R; Pertz, HH; Elz, S. Partial 5-HT2A-receptor agonists of the phenylethanamine series: Effect of a trifluoromethyl substituent Arch. Pharm. Pharm. Med. Chem., 3 May 2000, 333 (Suppl. 2), 45. 542 kB. #1 Poster abstract
Heim, R; Pertz, HH; Elz, MZS. Stereoselective synthesis, absolute configuration and 5-HT2A-receptor agonism of chiral 2-methoxybenzylamines Arch. Pharm. Pharm. Med. Chem., , 335 (Suppl. 1), 82. 573 kB. #3 Poster abstract
Uchiyama, N; Shimokawa, Y; Matsuda, S; Kawamura, M; Kikura-Hanajiri, R; Goda, Y. Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products Forensic Toxicol., 26 Nov 2013, 21 (1), 105-115. 827 kB. https://doi.org/10.1007/s11419-013-0217-2 #3 GC,LC,MS,NMR,UV
Hansen, M; Jacobsen, SE; Plunkett, S; Liebscher, GE; McCorvy, JD; Bräuner-Osborne, H; Kristensen, JL. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists Bioorg. Med. Chem., 15 Jun 2015, 23 (14), 3933-3937. 305 kB. https://doi.org/10.1016/j.bmc.2014.12.011
Leth-Petersen, S; Bundgaard, C; Hansen, M; Carnerup, MA; Kehler, J; Kristensen, JL. Correlating the metabolic stability of psychedelic 5-HT2A agonists with anecdotal reports of human oral bioavailability Neurochem. Res., 12 Feb 2014, 39 (10), 2018-2023. 625 kB. https://doi.org/10.1007/s11064-014-1253-y #4b
Brandt, SD; Elliott, SP; Kavanagh, PV; Dempster, NM; Meyer, MR; Maurer, HH; Nichols, DE. Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines Rapid Commun. Mass Spectrom., 2 Mar 2015, 29 (7), 573–584. 2.2 MB. https://doi.org/10.1002/rcm.7134 GC,LC,MS,UV
Chapman, SJ; Avanes, AA. PeakAL: Protons I Have Known and Loved — Fifty Shades of Grey-Market Spectra BLOTTER, 1 Aug 2015, 1 (1). 2.6 MB. https://doi.org/10.16889/isomerdesign-1 #B1 NMR
Chapman, SJ; Avanes, AA. PeakAL: Protons I Have Known and Loved — Fifty Shades of Grey-Market Spectra. Supplementary Data BLOTTER, 1 Aug 2015, 1 (1). 11.9 MB. https://doi.org/10.16889/isomerdesign-1-supp #B1 NMR
Hays, PA; Casale, JF. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3-and 4-methoxybenzyl analogues - Part II Microgram J., 1 Jan 2014, 11 (1–4), 3–22. 8.1 MB. #4: 25B-NB2OMe NMR
Prabhakaran, J; Underwood, MD; Kumar, JSD; Simpson, NR; Kassir, SA; Bakalian, MJ; Mann, JJ; Arango, V. Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors Bioorg. Med. Chem. Lett., 15 Sep 2015, 25 (18), 3933–3936. 603 kB. https://doi.org/10.1016/j.bmcl.2015.07.034 #2
Hyperlab. Hyperlab new compounds 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.
Edmunds, R; Donovan, R; Reynolds, D. The analysis of illicit 25X-NBOMe seizures in Western Australia Drug Test. Anal., 1 Apr 2018, 10 (4), 786-790. 507 kB. https://doi.org/10.1002/dta.2260 LC
Martins, D; Barratt, MJ; Pires, CV; Carvalho, H; Ventura, M; Fornís, I; Valente, H. The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal’s Boom Festival Hum. Psychopharmacol. Clin. Exp., 1 May 2017, 32 (3), e2608. 400 kB. https://doi.org/10.1002/hup.2608
Herth, MM; Petersen, IN; Hansen, HD; Hansen, M; Ettrup, A; Jensen, AA; Lehel, S; Dyssegaard, A; Gillings, N; Knudsen, GM; Kristensen, JL. Synthesis and evaluation of 18F-labeled 5-HT2A receptor agonists as PET ligands Nucl. Med. Biol., 1 Aug 2016, 43 (8), 455–462. 734 kB. https://doi.org/10.1016/j.nucmedbio.2016.02.011 #Cimbi-36 NMR
Leth-Petersen, S; Gabel-Jensen, C; Gillings, N; Lehel, S; Hansen, HD; Knudsen, GM; Kristensen, JL. Metabolic fate of hallucinogenic NBOMes Chem. Res. Toxicol., 19 Jan 2016, 29 (1), 96–100. 951 kB. https://doi.org/10.1021/acs.chemrestox.5b00450 #1, 11-13 See also Supporting information LC,NMR
Edgar, FG; Hansen, HD; Leth-Petersen, S; Ettrup, A; Kristensen, JL; Knudsen, GM; Herth, MM. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18F]Cimbi-92 and [18F]Cimbi-150 J. Labelled Compd. Radiopharm., 18 Sep 2017, 60 (12), 586-591. 494 kB. https://doi.org/10.1002/jlcr.3557 #Cimbi-36
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #66
Jensen, AA; McCorvy, JD; Leth-Petersen, S; Bundgaard, C; Liebscher, G; Kenakin, TP; Bräuner-Osborne, H; Kehler, J; Kristensen, JL. Detailed characterization of the in vitro pharmacological and pharmacokinetic properties of N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine (25CN-NBOH), a highly selective and brain-penetrant 5-HT2A receptor agonist J. Pharmacol. Exp. Ther., 1 Jun 2017, 361 (3), 441–453. 4.1 MB. https://doi.org/10.1124/jpet.117.239905 #Cimbi-36
Rickli, A; Luethi, D; Reinisch, J; Buchy, D; Hoener, MC; Liechti, ME. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) Neuropharmacology, 1 Dec 2015, 99, 546–553. 625 kB. https://doi.org/10.1016/j.neuropharm.2015.08.034 #25B-NBOMe
McGonigal, MK; Wilhide, JA; Smith, PB; Elliott, NM; Dorman, FL. Analysis of synthetic phenethylamine street drugs using direct sample analysis coupled to accurate mass time of flight mass spectrometry Forensic Sci. Int., 1 Jun 2017, 275, 83–89. 2.3 MB. https://doi.org/10.1016/j.forsciint.2017.02.025 #25B-NBOMe MS
Zawilska, JB; Andrzejczak, D. Next generation of novel psychoactive substances on the horizon – A complex problem to face Drug Alcohol Depend., 1 Jan 2015, 157, 1-17. 3.0 MB. https://doi.org/10.1016/j.drugalcdep.2015.09.030
Hansen, M; Phonekeo, K; Paine, JS; Leth-Petersen, S; Begtrup, M; Bräuner-Osborne, H; Kristensen, JL. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists ACS Chem. Neurosci., 19 Mar 2014, 5 (3), 243-249. 21.5 MB. https://doi.org/10.1021/cn400216u #2a NMR
Nichols, DE. Chemistry and structure–activity relationships of psychedelics In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 1-43. 2.6 MB. https://doi.org/10.1007/7854_2017_475 #76
Nichols, DE. Psychedelics Pharmacol. Rev., 1 Apr 2016, 68 (2), 264-355. 1.9 MB. https://doi.org/10.1124/pr.115.011478 Updated with published correction to Figure 4 (the α-methyl group was missing in the original)
Halberstadt, AL; Geyer, MA. Effect of hallucinogens on unconditioned behavior In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 159-199. 879 kB. https://doi.org/10.1007/7854_2016_466
Papoutsis, I; Nikolaou, P; Stefanidou, M; Spiliopoulou, C; Athanaselis, S. 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers Forensic Toxicol., 1 Jan 2015, 33 (1), 1-11. 365 kB. https://doi.org/10.1007/s11419-014-0242-9
King, LA. New phenethylamines in Europe Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
Lum, BJ; Brophy, JJ; Hibbert, DB. Identification of 4-substituted 2-(4-x-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25X-NBOMe) and analogues by gas chromatography–mass spectrometry analysis of heptafluorobutyric anhydride (HFBA) derivatives Aust. J. Forensic Sci., 2 Jan 2016, 48 (1), 59–73. 5.5 MB. https://doi.org/10.1080/00450618.2015.1026274 #25B-NBOMe GC,MS
Adamowicz, P; Zuba, D. Discrimination among designer drug isomers by chromatographic and spectrometric methods In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 211–232. 1.1 MB. LC,MS,IR,UV
Poklis, JL; Raso, SA; Alford, KN; Poklis, A; Peace, MR. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-methoxyphenyl)methyl]ethanamine derivatives on blotter paper J. Anal. Toxicol., 1 Oct 2015, 39 (8), 617–623. 495 kB. https://doi.org/10.1093/jat/bkv073 #25B-NBOMe LC,MS
Laskowski, LK; Elbakoush, F; Calvo, J; Exantus-Bernard, G; Fong, J; Poklis, JL; Poklis, A; Nelson, LS. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe J. Med. Toxicol., 1 Jun 2015, 11 (2), 237–241. 482 kB. https://doi.org/10.1007/s13181-014-0445-9 #25B-NBOMe LC
Souza, GA; Arantes, LC; Guedes, TJ; de Oliveira, AC; Marinho, PA; Muñoz, RAA; dos Santos, WTP. Voltammetric signatures of 2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamines on boron-doped diamond electrodes: Detection in blotting paper samples Electrochem. Commun., 1 Sep 2017, 82, 121–124. 748 kB. https://doi.org/10.1016/j.elecom.2017.08.001 #25B-NBOMe other
Caspar, AT; Brandt, SD; Stoever, AE; Meyer, MR; Maurer, HH. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC–MS, LC–MSn, and LC–HR–MS/MS approaches J. Pharm. Biomed. Anal., 5 Feb 2017, 134, 158–169. 842 kB. https://doi.org/10.1016/j.jpba.2016.11.040 #25B-NBOMe
Heim, R; Pertz, HH; Elz, S. Preparation and in-vitro pharmacology of novel secondary amine-type 5-HT2A-receptor agonists: From submillimolar to subnanomolar activity Arch. Pharm. Pharm. Med. Chem., , 331 (Suppl. 1), 34. 493 kB. #5 Poster abstract
Elz, S; Kläß, T; Heim, R; Warnke, U; Pertz, HH. Development of highly potent partial agonists and chiral antagonists as tools for the study of 5-HT2A-receptor mediated functions N-S. Arch. Pharmacol., , 365 (Suppl. 1), R29. 630 kB. #4
Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S2 Phenethylamines 25B-NBOMe
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #25B-NBOMe
Pertz, HH; Heim, R; Elz, S. N-Benzylated phenylethanamines are highly potent partial agonists at 5-HT2A receptors Arch. Pharm. Pharm. Med. Chem., , 333 (Suppl. 2), 30. 583 kB. #2a-OMe Poster abstract
Bork, W; Dahlenburg, R; Gimbel, M; Jacobsen-Bauer, A; Zörntlein, S. Herleitung Von Grenzwerten Der „nicht Geringen Menge“ Im Sinne Des Btmg Toxichem Krimtech, 1 Jan 2019, 86 (1), 5–91. 4.4 MB. #HP-020
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. Analytical data of designer drugs of synthetic phenethylamines JCCL, 1 Dec 2015, (55), 43–63. 637 kB. #2 Japanese, English abstract MS,NMR,IR,UV
Sexton, JD; Nichols, CD; Hendricks, PS. Population survey data informing the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics Front. Psychiatry, 11 Feb 2020, 10 (896). 529 kB. https://doi.org/10.3389/fpsyt.2019.00896 #25b-NBOMe
Poulie, CBM; Jensen, AA; Halberstadt, AL; Kristensen, JL. DARK Classics in Chemical Neuroscience: NBOMes ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3860-3869. 860 kB. https://doi.org/10.1021/acschemneuro.9b00528 #25B-NBOMe
Burgos-Villaseca, J; Klagges-Troncoso, J; Decker, A; Navarro, H; Brea, J; Sáez-Briones, P; Tirapegui, C; Cassels, BK. Caracterización farmacológica in vitro e in vivo del agonista serotoninérgico 5-HT2 superpotente 25B-NBOMe: Modulación de sus efectos inducida por bromación aromática ResearchGate, 1 Jan 2014. 382 kB. https://doi.org/10.13140/2.1.4332.8322 #25B-NB2OMe
Marcher-Rørsted, E; Halberstadt, AL; Klein, AK; Chatha, M; Jademyr, S; Jensen, AA; Kristensen, JL. Investigation of the 2,5-dimethoxy motif in phenethylamine serotonin 2A receptor agonists ACS Chem. Neurosci., 26 Mar 2020, 11 (9), 1238-1244. 3.8 MB. https://doi.org/10.1021/acschemneuro.0c00129 #20 LC,MS,NMR
Palamar, JJ; Acosta, P. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines Hum. Psychopharmacol. Clin. Exp., 1 Jan 2020, 35 (1), e2719. 764 kB. https://doi.org/10.1002/hup.2719 #25B-NBOMe
Elbardisy, HM; Foster, CW; Marron, J; Mewis, RE; Sutcliffe, OB; Belal, TS; Talaat, W; Daabees, HG; Banks, CE. Quick test for determination of N-bombs (Phenethylamine derivatives, NBOMe) using high-performance liquid chromatography: A comparison between photodiode array and amperometric detection ACS Omega, 10 Sep 2019, 4 (11), 14439–14450. 3.4 MB. https://doi.org/10.1021/acsomega.9b01366 #2c LC
Pottie, E; Cannaert, A; Stove, CP. In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor Arch. Toxicol., 1 Oct 2020, 94 (10), 3449–3460. 919 kB. https://doi.org/10.1007/s00204-020-02836-w #25B-NBOMe
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #25B-NBOMe spot
Juncosa, JI; Hansen, M; Bonner, LA; Cueva, JP; Maglathlin, R; McCorvy, JD; Marona-Lewicka, D; Lill, MA; Nichols, DE. Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands ACS Chem. Neurosci., 16 Jan 2013, 4 (1), 96-109. 3.8 MB. https://doi.org/10.1021/cn3000668 #2 MS,NMR
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #25B-NBOMe
Rørsted, EM; Jensen, AA; Kristensen, JL. 25CN‐NBOH: A selective agonist for in vitro and in vivo investigations of the serotonin 2A receptor ChemMedChem, 21 Aug 2021, 16 (21), 3263-3270. 1.7 MB. https://doi.org/10.1002/cmdc.202100395 #25B-NBOMe
Cumming, P; Scheidegger, M; Dornbierer, D; Palner, M; Quednow, BB; Martin-Soelch, C. Molecular and functional imaging studies of psychedelic drug action in animals and humans Molecules, 1 Jan 2021, 26 (9), 2451. 3.5 MB. https://doi.org/10.3390/molecules26092451 #38
de Oliveira Magalhães, L; Arantes, LC; Braga, JWB. Identification of NBOMe and NBOH in blotter papers using a handheld NIR spectrometer and chemometric methods Microchem. J., 1 Jan 2019, 144, 151–158. 2.7 MB. https://doi.org/10.1016/j.microc.2018.08.051 #25B-NBOMe
Halberstadt, AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens Behav. Brain Res., 15 Jan 2015, 277, 99–120. 4.1 MB. https://doi.org/10.1016/j.bbr.2014.07.016 #25B-NBOMe
Ettrup, A. Serotonin receptor studies in the pig brain: Pharmacological intervention and positron emission tomography tracer development Ph. D. Thesis, University of Copenhagen, 15 Nov 2010. 5.0 MB. #Cimbi-36 NMR
Martins, D; Gil-Martins, E; Cagide, F; Da Fonseca, C; Benfeito, S; Fernandes, C; Chavarria, D; Remião, F; Silva, R; Borges, F. Unraveling the in vitro toxicity profile of psychedelic 2C phenethylamines and their N-benzylphenethylamine (NBOMe) analogues Pharmaceuticals, 15 Aug 2023, 16 (8), 1158. 6.0 MB. https://doi.org/10.3390/ph16081158 #25B-NBOMe MS,NMR
Leth-Petersen, S; Petersen, IN; Jensen, AA; Bundgaard, C; Bæk, M; Kehler, J; Kristensen, JL. 5-HT2A/5-HT2C receptor pharmacology and intrinsic clearance of N-benzylphenethylamines modified at the primary site of metabolism ACS Chem. Neurosci., 16 Nov 2016, 7 (11), 1614–1619. 684 kB. https://doi.org/10.1021/acschemneuro.6b00265 #1
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #108, 117, 142